Birmingham, AL, United States of America

Hong-Yin Wu

This inventor holds 4 USPTO granted patents. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong-Yin Wu. Retrieved from https://idiyas.com/inventor/hong-yin-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 89(Granted Patents)


Location History:

  • Birmingham, AL (US) (1999 - 2000)
  • Hoover, AL (US) (2000)

Company Filing History:


Years Active: 1999-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong-Yin Wu

Introduction

Hong-Yin Wu is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of immunology, particularly in the development of novel vaccines and immunogenic compositions. With a total of 4 patents to her name, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents focuses on immunogenic compositions for mucosal administration of pneumococcal. This invention involves the intranasal administration of killed whole pneumococci, lysate of pneumococci, and isolated and purified PspA. When administered with cholera toxin B subunit, this approach provides protection in animals against pneumococcal colonization and systemic infection. The ability to elicit protection against pneumococcal colonization in a host is crucial, as it can prevent carriage among immunized individuals, ultimately leading to the elimination of disease from the population.

Another significant patent involves mucosal immunogens for novel vaccines. This invention provides chimeric proteins, such as Salivary Binding Protein (SBR) coupled to the B subunit of cholera toxin. When expressed in attenuated Salmonella typhimurium, this chimeric protein produces significant increases in serum IgG and salivary IgA antibody levels after oral immunization. Additionally, the recombinant plasmid containing a salivary binding protein-cholera toxin A2/B chimeric protein expressed in E. coli leads to increased antigen-responsive T cells. Oral immunization using this recombinant plasmid results in enhanced serum IgG and salivary IgA antibody responses to the antigen.

Career Highlights

Hong-Yin Wu is associated with the UAB Research Foundation, where she continues her innovative work in immunology. Her research has garnered attention for its potential applications in vaccine development and disease prevention.

Collaborations

Some of her notable coworkers include David E. Briles and Michael W. Russell, who have collaborated with her on various research projects.

Conclusion

In summary, Hong-Yin Wu is an influential inventor whose work in immunogenic compositions and novel vaccines holds promise for improving public health outcomes. Her contributions to the field are noteworthy and continue to inspire further research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…